News und Analysen
Stock Market Today, Jan. 16: ImmunityBio Soars After Anktiva Revenue Jumps 700 Percent Year Over Year
ImmunityBio (NASDAQ:IBRX), cancer and infectious disease immunotherapy developer, closed Friday at $5.52, up 39.75% for the session. The stock climbed after Premarket updates highlighted explosive
Why ImmunityBio Stock Is Skyrocketing Again Today
Shares of cancer and infectious disease therapy developer ImmunityBio, Inc. (NASDAQ: IBRX), spiked 34% higher as of 1 p.m. ET on Friday and are now up a staggering 127% this week after an incredible
Why Shares of Riot Platforms Are Surging Today
Shares of the Bitcoin miner Riot Platforms (NASDAQ: RIOT) traded nearly 13.5% higher today, as of 1:11 p.m. ET. The company announced the acquisition of land and a lease agreement with chipmaker
Why InterDigital Could Be a Huge AI Winner That Investors Ignore at Their Peril
The amazing returns that technology stocks have generated for more than a decade now have attracted countless investors to the sector. Many of the best-known tech stocks profit from creating
3 Dividend Champions to Buy and Hold for Decades
There's a saying on Wall Street that "dividends don't lie." Just about every financial metric can be spun by a company's management, but dividends either arrive in the mail or they don't. Companies
UnitedHealth at an Inflection Point: Margin Recovery or Prolonged Challenges?
In 2025, UnitedHealth Group (NYSE: UNH) faced a notable increase in medical costs amid other challenges, forcing management to cut its earnings guidance in April before withdrawing it completely a
Nvidia H200 and AMD MI325X Got Hit With New Tariffs
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other AI stocks. To learn more, check out the short video, consider subscribing,
Stock Market Today, Jan. 15: Nvidia Rises on Strong AI Demand and Data Center Growth Optimism
Nvidia (NASDAQ:NVDA), the leading developer of GPUs and AI solutions for data centers, closed Thursday at $187.05, up 2.13%. Shares moved higher as investors responded to renewed evidence of robust
Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%
ImmunityBio (NASDAQ:IBRX), a cancer and infectious-disease drug developer, closed Thursday at $3.95, up 30.79% for the session. The stock jumped after preliminary 2025 results highlighted roughly
3 Absurdly Cheap Growth Stocks to Buy in 2026
If you want to set yourself up for good long-term returns, it's important to consider a stock's valuation. Even if you invest in great companies, if you're paying a massive premium for them, your
Is AMD Stock a Buy After Its CES Keynote?
In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special
Why AMD and Intel Shareholders Could Have a Strong Year
In today's video, I discuss recent updates affecting Intel (NASDAQ: INTC), Advanced Micro Devices (NASDAQ: AMD), and other AI stocks. To learn more, check out the short video, consider subscribing,
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2025: Record net sales and significant earnings growth – forecast for 2026
2 Artificial Intelligence (AI) Stocks Poised to Run in 2026 and Beyond
Top technology companies that are meeting the demand for chips and other artificial intelligence compute requirements have delivered excellent returns to investors over the past few years.
Leading
Why Voyager Technologies Stock Surged Today
Leading the team of companies planning to build a privately owned Starlab space station to replace the International Space Station in 2030, Voyager Technologies (NYSE: VOYG) arguably has the best
Is UnitedHealth Group Stock a Buy, Sell, or Hold in 2026?
UnitedHealth Group (NYSE: UNH) is coming off a brutal 2025, when its stock lost a staggering 35% in value, despite the markets enjoying a fairly strong year with the S&P 500 climbing by 16%
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025
EQS-News: Sartorius expands bio-circular product offering for more sustainable bioprocesses
Should You Buy Shares of UnitedHealth In January?
The S&P 500 marched on to its third consecutive annual gain in 2025, but one of the country's market leaders missed out on this momentum. I'm talking about UnitedHealth Group (NYSE: UNH), the U.S.'
Stock Market Today, Jan. 13: Nvidia Rises on H200 Export Developments
AI giant, Nvidia (NASDAQ:NVDA), closed Tuesday’s session at $185.81, up 0.47%. Trading volume reached 158.40 million shares, coming in 16.51% below its three-month average of 184.56 million shares.
Stock Market Today, Jan. 13: AMD Rallies as Banking Stocks Struggle
The S&P 500 (SNPINDEX:^GSPC) slipped 0.19% to 6,963.74 today even as December CPI data came in slightly lower than expected. The Nasdaq Composite (NASDAQINDEX:^IXIC) eased 0.10% to 23,709.87, and
1 Quantum Computing Stock to Buy that Could Soar in 2026
Quantum computing is moving from the theoretical to the commercially applicable, but only one company has achieved 99.99% two-qubit gate fidelity (a measure of results accuracy). That company is
This Top Gold Stock Could Keep Climbing in 2026
As economic uncertainty has grown, investors have increasingly turned to gold as an alternative to traditional investments in stocks, bonds, and other asset classes. Gold soared in 2025, and already
Buy These 3 AI ETFs Now: They Could Be Worth $15 Million in 30 Years
There is no hotter segment of the market right now than artificial intelligence (AI). AI stocks have powered the market higher over the past few years, and the technology still looks like it is in
Prediction: This Artificial Intelligence (AI) Chip Stock Will Outperform Nvidia in 2026 (Hint: It's Not AMD)
The rise of artificial intelligence (AI) has ushered in a generational growth wave for companies all across the technology arena. In particular, semiconductor stocks have been some of the greatest



